Home LiteratureArticle Details
PMID: 1185015 Published · ppublish English Journal Article

Experimental osteomyelitis. IV. Therapeutic trials with rifampin alone and in combination with gentamicin, sisomicin, and cephalothin.

The Journal of infectious diseases ·Vol. 132 ·No. 5 ·1975-11-00 ·Pages 493-9

Norden CW

Abstract

Levels of rifampin, gentamicin, sisomicin, and cephalothin in normal and osteomyelitic rabbit bones were measured, and the efficacy of these drugs in the treatment of osteomyelitis was evaluated. Single drug regimens, including rifampin for 14 days and gentamicin, sisomicin, and cephalothin each for 28 days, were relatively ineffective (5%-33% sterile bone cultures). Rifampin, administered for 28 days, sterilized the bones of 55% of treated animals. The combination of gentamicin and rifampin, given for either 14 or 28 days, sterilized the bones of 67% of treated animals. The combinations of rifampin plus sisomicin and of rifampin plus cephalothin, given for 28 days, were significantly more effective than these agents alone, sterilizing 90%-95% of bones. The combination of rifampin, sisomicin, and cephalothin, given for only 14 days, sterilized the bones of all treated rabbits. Staphylococci isolated from the bones of therapeutic failures that had received rifampin alone or in combination with other antibiotics were highly resistant to rifampin (minimal inhibitory concentration, greater than 250 mug/ml), whereas the organisms recovered from animals not receiving rifampin remained sensitive. Results of in vitro studies of synergy and/or bactericidal activity of antibiotic combinations correlated with in vivo results in some, but not all, instances.

MeSH Terms
Animals Anti-Bacterial Agents/therapeutic use Cephalothin/therapeutic use Disease Models, Animal Drug Evaluation, Preclinical Drug Resistance, Microbial Drug Synergism Drug Therapy, Combination Gentamicins/therapeutic use Osteomyelitis/drug therapy,microbiology Rabbits Rifampin/therapeutic use Sisomicin/therapeutic use Staphylococcus aureus/drug effects
Chemicals
Anti-Bacterial Agents Gentamicins Cephalothin Rifampin Sisomicin
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Norden C W
Article Info
Journal
The Journal of infectious diseases
Abbr.
J Infect Dis
ISSN
0022-1899
Published
1975-11-00
Pages
493-9
Language
English
Region
United States
NLM ID
0413675
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com